These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1014113)

  • 1. [In vitro development of macrophages from PHA-stimulated blood cultures in Hodgkin's disease and in chronic lymphocytic leukaemia (author's transl)].
    Navone R; Tosto M; Poggio E
    Tumori; 1976; 62(1):19-24. PubMed ID: 1014113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies of macrophages in blood cultures in Hodgkin's disease.
    Novone R; Palestro G; Resegotti L
    Acta Haematol; 1975; 53(1):25-9. PubMed ID: 807071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
    Ambrogi F; Grassi B; Ronca-Testoni S; Ronca G
    Clin Exp Immunol; 1977 Apr; 28(1):80-8. PubMed ID: 405169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Correlation between some enzymes of nucleotide catabolism, E rosette formation and PHA response of blood lymphocytes in Hodgkin's disease and chronic lymphocytic leukemia.
    Ronca G; Ronca Testoni S; Grassi B; Ambrogi F
    Ital J Biochem; 1976; 25(3):255-6. PubMed ID: 955858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of Hodgkin cytotoxic serum on blast transformation of normal and Hodgkin human peripheral blood lymphocytes].
    Tognella S; Mantovani G; Del Giacco GS; Manconi PE; Cengiarotti L; Floris C; Grifoni V
    Tumori; 1975; 61(1):53-62. PubMed ID: 1226572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte transformation in immunoproliferative disorders.
    Catovsky D; Holt PJ; Galton DA
    Br J Cancer; 1972 Jun; 26(3):154-63. PubMed ID: 4114813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PHA- and PWM-stimulation in acute leukaemia (author's transl)].
    Koeppen KM; Boll I
    Blut; 1978 Jun; 36(6):347-351. PubMed ID: 274967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Mintz U; Sachs L
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2428-32. PubMed ID: 1056037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the circulating cell in chronic lymphocytic leukemia.
    Schultz EF; Davis S; Rubin AD
    Blood; 1976 Aug; 48(2):223-34. PubMed ID: 1065390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
    Twomey JJ; Laughter AH; Lazar S; Douglass CC
    Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.